Coeptis Therapeutics Inc (COEP) — Financial Flexibility Index
Coeptis Therapeutics Inc (COEP) has a Financial Flexibility Index of -0.66x as of September 2025. Free cash flow of $-2.15 Million (operating CF $-2.15 Million minus capex $3.00) represents -1% of total liabilities ($3.26 Million). Check COEP cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Coeptis Therapeutics Inc Financial Flexibility Index (2004–2024)
Historical Financial Flexibility Index trend for Coeptis Therapeutics Inc across 9 annual periods. For the full cash flow conversion analysis, see how efficiently does Coeptis Therapeutics Inc generate cash.
Annual Financial Flexibility Index for Coeptis Therapeutics Inc (2004–2024)
Year-by-year free cash flow to debt coverage for Coeptis Therapeutics Inc. Explore COEP operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.32x | $-6.65 Million | $-6.65 Million | $5.04 Million | ▼ -17.8% |
| 2023 | -1.12x | $-3.88 Million | $-3.88 Million | $3.46 Million | ▲ +10.1% |
| 2022 | -1.25x | $-3.88 Million | $-3.88 Million | $3.11 Million | ▼ -100.7% |
| 2021 | -0.62x | $-2.74 Million | $-4.49 Million | $4.41 Million | ▼ -7.7% |
| 2020 | -0.58x | $-3.14 Million | $-3.14 Million | $5.44 Million | ▲ +0.3% |
| 2019 | -0.58x | $-90.03K | $-90.07K | $155.85K | ▲ +95.7% |
| 2018 | -13.47x | $-836.27K | $-839.06K | $62.07K | ▼ -2178.3% |
| 2005 | -0.59x | $-417.02K | $-417.02K | $705.22K | ▼ -111.8% |
| 2004 | 5.00x | $1.55 Million | $1.55 Million | $310.94K | — |